Building an unbreakable Chain of Compliance® - BioPharma Dealmakers

November 06, 2018

Regenerative medicine advanced therapies in the form of cell and gene therapies are breaking new ground, providing patients the potential of treatment, reversal or even cure of serious and life-threatening conditions, including genetic disorders and cancer. The logistics and supply chains for these therapies, particularly those that involve the manipulation of autologous cells, can be complex, and there are many points in the chain in which the cells are vulnerable to accidental diversion or temperature deviation. In a recent feature in BioPharma Dealmakers, the importance of Chain of Compliance® is revealed and explained:  Read Full Article >

Questions or comments? We welcome your feedback!

Email Us

Tags: Clinical Trials Logistics, Temperature Controlled Logistics, Chain of Compliance®

Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC